Cited by 118Pancreatic and Hepatic Oncology ResearchCardiac, Anesthesia and Surgical OutcomesCholangiocarcinoma and Gallbladder Cancer Studies

Patient readmission and mortality after surgery for hepato-pancreato-biliary malignancies

Open access
Schneider, Eric B., Hyder, Omar, Wolfgang, Christopher L., Hirose, Kenzo, Choti, Michael A., Makary, Martin A., Herman, Joseph M., Cameron, John L. +1 more·2012·Journal of the American College of Surgeons

Abstract

BACKGROUND: The incidence and associated risk factors for readmission after hepato-pancreato-biliary surgery are poorly characterized. The objective of the current study was to compare readmission after pancreatic vs hepatobiliary surgical procedures, as well as to identify potential factors associated with higher readmission within 30 days of discharge. STUDY DESIGN: Using Surveillance, Epidemiology and End Results-Medicare linked data from 1986-2005, we identified 9,957 individuals aged 66 years and older who underwent complex hepatic, biliary, or pancreatic procedures for cancer treatment and were eligible for analysis. In-hospital morbidity, mortality, and 30-day readmission were examined. RESULTS: Primary surgical treatment consisted of a pancreatic (46.7%), hepatic (50.0%), or biliary (3.4%) procedure. Mean patient age was 72.6 years and most patients were male (53.2%). The number of patients with multiple preoperative comorbidities increased over time (patients with Elixhauser's comorbidity score >13: 1986-1990, 47.0% vs 2001-2005, 62.9%; p < 0.001). Pancreatic operations had higher inpatient mortality vs hepatobiliary procedures (9.2% vs 7.3%; p < 0.001). Mean length of stay after pancreatic procedures was longer compared with hepatobiliary procedures (19.7 vs 10.3 days; p < 0.001). The proportion of patients readmitted after a pancreatic (1986-1990, 17.7%; 1991-1995, 16.1%; 1996-2000, 18.6%; 2001-2005, 19.6%; p = 0.15) or hepatobiliary (1986-1990, 14.3%; 1991-1995, 14.1%; 1996-2000, 15.2%; 2001-2005, 15.5%; p = 0.69) procedure did not change over time. Factors associated with increased risk of readmission included preoperative Elixhauser comorbidities >13 (odds ratio = 1.90) and prolonged index hospital stay ≥10 days (odds ratio = 1.54; both p < 0.05). During the readmission, additional morbidity and mortality were 46.5% and 8.0%, respectively. CONCLUSIONS: Although the incidence of readmission did not change across the time periods examined, readmission was higher among patients undergoing a pancreatic procedure vs a hepatobiliary procedure. Other factors associated with risk of readmission included number of patient comorbidities and prolonged hospital stay. Readmission was associated with additional short-term morbidity and mortality.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jamcollsurg.2012.07.007

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Disseminated cancer, a pre-operative open wound, and dyspnea are examples of comorbidities tied to early readmission in prior studies.

    “Examples of existing comorbidities associated with early readmission include disseminated cancer, pre-operative open wound, and dyspnea.”

    From Clinical predictors and outcome implications of early readmission in lung transplant recipients (2017) · cites this paper as [12]

    The Results (Readmission analyses; page unavailable) associate a higher overall comorbidity score with readmission within 30 days. The paper does not identify disseminated cancer, a pre-operative open wound, or dyspnea as individual readmission risk factors; searches for those terms found no such analysis. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • Prior work has linked certain pre-existing conditions to higher 30-day readmission rates after surgery.

    “This finding is inconsistent with other studies, in which authors have observed significant relationships between specific pre-existing conditions and increased rates of 30-day readmission in surgical patients.7,12”

    From Clinical predictors and outcome implications of early readmission in lung transplant recipients (2017) · cites this paper as [12]

    The Results (Readmission analyses; page unavailable) report a significant association between a higher Elixhauser comorbidity score and increased 30-day readmission after hepato-pancreato-biliary surgery. The paper measures pre-existing conditions but reports this finding for a composite score, not significant relationships with specific individual conditions. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [17]Mayo SC Gilson MM Herman JM Management of patients with pancreatic adenocarcinoma: national trends in patient selection, operative management, and use of adjuvant therapy J Am Coll Surg 2012 214 33 45 22055585 PMC3578342

Cited by

Sorted by citations

Authors
Schneider, E. B., Hyder, O., Wolfgang, C. L., Hirose, K., Choti, M. A., Makary, M. A., Herman, J. M., Cameron, J. L., & Pawlik, T. M.
Affiliations
Johns Hopkins University (US)
Corresponding author
Pawlik, Timothy M.
Venue
Journal of the American College of Surgeons
Published
2012-11
Volume
215
Issue
5
Pages
607-615
ISSN
1072-7515 (ISSN-L)
OpenAlex
W1977427217
Cited by
118
References
23
Citations by year
2025: 4 · 2024: 3 · 2023: 1 · 2022: 4 · 2021: 9 · 2020: 10 · 2019: 5 · 2018: 14 · 2017: 6 · 2016: 8 · 2015: 22 · 2014: 21 · 2013: 10 · 2012: 1
FWCI
8.71
Type
journal article
Language
en
Open access
Locations
  • Journal of the American College of Surgeons (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Cancer Institute (P30CA006973)
Topics
  • Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac, Anesthesia and Surgical Outcomes
  • Health Sciences › Medicine › Surgery › Cholangiocarcinoma and Gallbladder Cancer Studies
Keywords
hospital readmission, postoperative mortality, hepatopancreatobiliary surgery, pancreatic cancer surgery, 30-day readmission, Elixhauser comorbidity index, preoperative comorbidities, length of hospital stay, Medicare beneficiaries, older adults, risk factors for readmission, temporal trends in surgical outcomes, SEER
MeSH terms
Aged, Aged, 80 and over, Biliary Tract Neoplasms, Female, Medicare, Humans, Length of Stay, Liver Neoplasms, Male, Pancreatic Neoplasms, Patient Readmission, Postoperative Complications, Retrospective Studies, Digestive System Surgical Procedures, United States, Cohort Studies, Multivariate Analysis, Logistic Models, Survival Analysis, Treatment Outcome, Hospital Mortality, SEER Program

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review